Podcast
Questions and Answers
What is the primary mechanism of action of thromboxane A2 inhibitors like aspirin?
What is the primary mechanism of action of thromboxane A2 inhibitors like aspirin?
- Inhibition of COX 1/2 enzymes leading to decreased TxA2 production (correct)
- Direct stimulation of vasopressin to enhance platelet function
- Inhibition of fibrinogen binding to platelet receptors
- Inhibition of platelet aggregation through ADP release
Which of the following is a common side effect associated with phosphodiesterase 3 inhibitors?
Which of the following is a common side effect associated with phosphodiesterase 3 inhibitors?
- Elevated blood pressure
- Headaches (correct)
- Increased heart rate
- Diarrhea
In which condition is the use of antiplatelets particularly indicated?
In which condition is the use of antiplatelets particularly indicated?
- Acute stroke
- Acute liver failure
- Unstable angina (correct)
- Severe dehydration
What is a contraindication for the use of antiplatelets in children?
What is a contraindication for the use of antiplatelets in children?
What is the effect of an increase in cAMP levels in relation to platelet function?
What is the effect of an increase in cAMP levels in relation to platelet function?
Flashcards
Aspirin Mechanism of Action
Aspirin Mechanism of Action
Aspirin inhibits COX-1 and COX-2 enzymes, preventing the production of Thromboxane A2 (TXA2). This, in turn, reduces platelet aggregation by inhibiting fibrinogen binding, von Willebrand factor release, and calcium influx.
PDE-3 Inhibitor Mechanism
PDE-3 Inhibitor Mechanism
Dipyridamole and cilostazol inhibit phosphodiesterase 3 (PDE-3), preventing the breakdown of cyclic AMP (cAMP). This leads to increased cAMP levels, which ultimately inhibits platelet aggregation by reducing calcium influx.
Antiplatelet Side Effects
Antiplatelet Side Effects
Common side effects of antiplatelet drugs include bleeding, headaches, and chest pain. These can occur due to the drugs' ability to inhibit platelet aggregation, making it harder for the body to form clots. Therefore, individuals taking antiplatelet medications should be monitored for any signs of bleeding.
Antiplatelet Indications
Antiplatelet Indications
Signup and view all the flashcards
Antiplatelet Contraindications
Antiplatelet Contraindications
Signup and view all the flashcards
Study Notes
Antiplatelet Drugs
-
Thromboxane A2 Inhibitors (Aspirin): Inhibit cyclooxygenase (COX) enzymes (COX 1/2), preventing thromboxane A2 production. This reduces fibrinogen adhesion, vWF, calcium, and ADP release, thereby inhibiting platelet aggregation.
-
Side Effects (Aspirin): Chest pain, bleeding
-
Indications (Aspirin): Pain, fever.
-
Contraindications (Aspirin): Allergies. Children may not bind with fibrinogen leading to issues with platelet plug formation
-
Phosphodiesterase 3 Inhibitors (Dipyridamole, Cilostazol): Normally, phosphodiesterase 3 converts cyclic AMP (cAMP) to AMP. Inhibiting PDE-3 prevents this conversion, increasing cAMP levels, which decreases intracellular calcium and inhibits platelet aggregation.
-
Side Effects (Dipyridamole, Cilostazol): Bleeding, headaches.
-
Indications (Dipyridamole, Cilostazol): Antiplatelet therapy for conditions like COPD, erectile dysfunction, benign prostatic hyperplasia (BPH).
-
Contraindications (Dipyridamole, Cilostazol): Myocardial infarction (MI), hypertension, hypotension, stroke within the past three months, bleeding.
-
General Antiplatelet Indications: Unstable angina, non-ST-elevation myocardial infarction (NSTEMI).
-
General Antiplatelet Contraindications: Bleeding, kidney disease, old age
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz covers key aspects of antiplatelet drugs, including thromboxane A2 inhibitors like aspirin and phosphodiesterase 3 inhibitors such as dipyridamole and cilostazol. It addresses their mechanisms, indications, side effects, and contraindications. Test your knowledge of these important medications and their roles in managing cardiovascular conditions.